Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 79

1.

Genetically increased risk of sleep disruption in Alzheimer's disease.

Craig D, Hart DJ, Passmore AP.

Sleep. 2006 Aug;29(8):1003-7.

PMID:
16944667
2.
3.

Interleukin 6-174 G/C promoter and variable number of tandem repeats (VNTR) gene polymorphisms in sporadic Alzheimer's disease.

Capurso C, Solfrizzi V, Colacicco AM, D'Introno A, Frisardi V, Imbimbo BP, Lorusso M, Vendemiale G, Denitto M, Santamato A, Seripa D, Pilotto A, Fiore P, Capurso A, Panza F.

Prog Neuropsychopharmacol Biol Psychiatry. 2010 Feb 1;34(1):177-82. doi: 10.1016/j.pnpbp.2009.10.022. Epub 2009 Nov 6.

PMID:
19897004
4.

Neuropathologic intermediate phenotypes enhance association to Alzheimer susceptibility alleles.

Bennett DA, De Jager PL, Leurgans SE, Schneider JA.

Neurology. 2009 Apr 28;72(17):1495-503. doi: 10.1212/WNL.0b013e3181a2e87d.

5.

Role of BDNF Val66Met functional polymorphism in Alzheimer's disease-related depression.

Borroni B, Archetti S, Costanzi C, Grassi M, Ferrari M, Radeghieri A, Caimi L, Caltagirone C, Di Luca M, Padovani A; ITINAD Working Group.

Neurobiol Aging. 2009 Sep;30(9):1406-12. doi: 10.1016/j.neurobiolaging.2007.11.023. Epub 2008 Jan 7.

PMID:
18179845
6.

Association of apolipoprotein E genetic variation in Alzheimer's disease in Indian population: a meta-analysis.

Agarwal R, Tripathi CB.

Am J Alzheimers Dis Other Demen. 2014 Nov;29(7):575-82. Review.

PMID:
25551132
7.

Haplogroup analysis of the risk associated with APOE promoter polymorphisms (-219T/G, -491A/T and -427T/C) in Colombian Alzheimer's disease patients.

Parra-Bonilla G, Arboleda G, Yunis J, Solano E, Pardo R, Arango G, Hedmont D, Arboleda H.

Neurosci Lett. 2003 Oct 9;349(3):159-62.

PMID:
12951193
8.

Monoamine oxidase a polymorphism in Brazilian patients: risk factor for late-onset Alzheimer's disease?

Nishimura AL, Guindalini C, Oliveira JR, Nitrini R, Bahia VS, de Brito-Marques PR, Otto PA, Zatz M.

J Mol Neurosci. 2005;27(2):213-7.

PMID:
16186632
9.

The APOE polymorphism in Alzheimer's disease patients with neuropsychiatric symptoms and syndromes.

D'Onofrio G, Panza F, Seripa D, Sancarlo D, Paris F, Cascavilla L, Urbano M, Gravina C, Fontana A, Solfrizzi V, Pellegrini F, Pilotto A.

Int J Geriatr Psychiatry. 2011 Oct;26(10):1062-70. doi: 10.1002/gps.2644. Epub 2010 Oct 29.

PMID:
21905100
10.

The 5HTT and MAO-A polymorphisms associate with depressive mood and climacteric symptoms in postmenopausal women.

Grochans E, Grzywacz A, Jurczak A, Samochowiec A, Karakiewicz B, Brodowska A, Starczewski A, Samochowiec J.

Prog Neuropsychopharmacol Biol Psychiatry. 2013 Aug 1;45:125-30. doi: 10.1016/j.pnpbp.2013.05.007. Epub 2013 May 23.

PMID:
23707423
11.
12.

Risk for Alzheimer's disease correlates with transcriptional activity of the APOE gene.

Artiga MJ, Bullido MJ, Frank A, Sastre I, Recuero M, García MA, Lendon CL, Han SW, Morris JC, Vázquez J, Goate A, Valdivieso F.

Hum Mol Genet. 1998 Nov;7(12):1887-92.

PMID:
9811931
14.

Interleukin-1β Promoter Polymorphism Enhances the Risk of Sleep Disturbance in Alzheimer's Disease.

Yin Y, Liu Y, Pan X, Chen R, Li P, Wu HJ, Zhao ZQ, Li YP, Huang LQ, Zhuang JH, Zhao ZX.

PLoS One. 2016 Mar 3;11(3):e0149945. doi: 10.1371/journal.pone.0149945. eCollection 2016.

15.

Apolipoprotein E genotype is not associated with cognitive impairment in older adults with bipolar disorder.

Kerr DS, Stella F, Radanovic M, Aprahamian I, Bertollucci PH, Forlenza OV.

Bipolar Disord. 2016 Feb;18(1):71-7. doi: 10.1111/bdi.12367. Epub 2016 Feb 15.

PMID:
26877211
16.

Interleukin 6-174 G/C promoter gene polymorphism and sporadic Alzheimer's disease: geographic allele and genotype variations in Europe.

Capurso C, Solfrizzi V, D'Introno A, Colacicco AM, Capurso SA, Capurso A, Panza F.

Exp Gerontol. 2004 Oct;39(10):1567-73. Review.

PMID:
15501028
17.

Polymorphisms of the human apolipoprotein E promoter and bleomycin hydrolase gene: risk factors for Alzheimer's dementia?

Thome J, Gewirtz JC, Sakai N, Zachariou V, Retz-Junginger P, Retz W, Duman RS, Rösler M.

Neurosci Lett. 1999 Oct 15;274(1):37-40.

PMID:
10530514
18.

Apolipoprotein E genotypes and plasma levels in mild cognitive impairment conversion to Alzheimer's disease: A follow-up study.

Scarabino D, Broggio E, Gambina G, Maida C, Gaudio MR, Corbo RM.

Am J Med Genet B Neuropsychiatr Genet. 2016 Dec;171(8):1131-1138. doi: 10.1002/ajmg.b.32495. Epub 2016 Sep 8.

PMID:
27604972
19.

Associations between depression, sleep disturbance, and apolipoprotein E in the development of Alzheimer's disease: dementia.

Burke SL, Maramaldi P, Cadet T, Kukull W.

Int Psychogeriatr. 2016 Sep;28(9):1409-24. doi: 10.1017/S1041610216000405. Epub 2016 Mar 29.

20.

APOE*4-associated Alzheimer's disease risk is modified by alpha 1-antichymotrypsin polymorphism.

Kamboh MI, Sanghera DK, Ferrell RE, DeKosky ST.

Nat Genet. 1995 Aug;10(4):486-8. Erratum in: Nat Genet 1995 Sep;11(1):104.

PMID:
7670501

Supplemental Content

Support Center